Patents Assigned to Pharming
USING C1 ESTERASE INHIBITOR TO TREAT VIRAL INFECTION-RELATED ACUTE RESPIRATORY DISTRESS
Publication number: 20210324107
Abstract: The claimed invention relates to treatment of virus-related respiratory distress, particularly methods for treating such distress by administering a complement inhibitor. The types of virus-related respiratory distress that can be treated according to the invention include acute respiratory distress syndrome and related phenomena, and can be linked to infection by a coronavirus such as SARS-CoV-2. The invention includes administering complement inhibitor, which can be recombinant or purified Cl inhibitor, and administering complement inhibitor in combination with other therapeutics.
Type: Application
Filed: April 19, 2021
Publication date: October 21, 2021
Applicant: Pharming Intellectual Property B.V.
Inventors: Bruno GIANNETTI, Jürgen SCHAALE, Anurag RELAN
Was dit voorlopig het laatste ingeschreven patent bij Pharming Intellectual Property bv, of zijn nieuwe ,reeds aangevraagde patenten, nog onderweg.